Download

Download eBook for Free

FormatFile SizeNotes
PDF file 0.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Purchase

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback98 pages $20.00 $16.00 20% Web Discount

Portugal recently changed its drug policy by adopting a strategy based upon a series of principles to contain and reduce the negative effects of substance abuse. The flagship of this strategy is the decriminalization of consumption of all types of drugs and possession of these drugs for personal use. The strategy has begun to be implemented through a series of laws and administrative decisions, of which the decriminalization law took effect on 1 July 2001. Other laws address harm reduction, risk reduction, prevention, treatment and rehabilitation. This report analyzes the new Portuguese Drug Strategy and develops recommendations for its implementation and evaluation. To do this, it examines the history of Portuguese society and its drug problem over the past 75 years, looks in detail at the strategy, proposed laws and action plans, and examines them in light of the existing literature on drugs and drug abuse. The main question addressed in this project was: Which parts of the National Drug Strategy deserve priority in its implementation and how should the effects of implementation of the Strategy be evaluated? This was divided into three subquestions: (1) What are the objectives of the National Drug Strategy? (2) What are the most appropriate ways of prioritizing the individual components of the National Drug Strategy? and (3) How can the real effects of the National Drug Strategy be assessed?

Research conducted by

The research described in this report was performed within RAND Europe.

This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.